Top Markets
#1 Black Phoenix Black Phoenix +828.22%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.74%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.29%
#4 Bless Bless +21.01%
#5 SAFEcoin SAFEcoin +20.57%
#6 pipedog pipedog +20.53%
#7 Magma Finance Magma Finance +20.34%
#8 PondCoin PondCoin +20.03%
#9 Beam Beam +19.60%
#10 YFSX YFSX +16.01%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Classificação em ações #6151
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Preço da ação
$153.93
Valor de mercado
$2.21B
Variação (1 dia)
-0.26%
Variação (1 ano)
172.68%
País
US
Negociar Palvella Therapeutics, Inc. (PVLA)

Categoria

Healthcare
Lucros da Palvella Therapeutics, Inc. (PVLA)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Palvella Therapeutics, Inc., os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Palvella Therapeutics, Inc. de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH